FDA Inspection 915060 — Apotex Inc.

Apotex Inc. — FEI 3001617666

The FDA completed an inspection of Apotex Inc. on Mar 4, 2015 in Richmond Hill. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Mar 4, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Richmond Hill (Canada)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.